Financial Conduct Authority’s reforms to London listing rules do not fill business leaders with confidence, survey suggests.

AstraZeneca’s chief executive, Sir Pascal Soriot, tops the list with £16.85m, High Pay Centre research reveals.

Today’s King’s Speech included a declaration that the UK would get a draft audit reform and corporate governance bill.

Cherry picking US elements such as dual-class shares can’t ensure success in attracting IPOs, ICGN conference heard.

There is to be no shareholder approval for ‘significant transactions’, nor a need for a sunset clause on dual-class shares.

New listings rules could be the ‘antidote’ to short-termism in the market, according to the Chartered Governance Institute.

Listing a company with questionable human rights due diligence is not ‘healthy’ for a stock exchange, writes investment CEO.

Suggested changes to the UK listings regime had come under fire from LAPFF, a £350bn pension funds investment body.

Proposed governance changes lack supporting evidence and may not bring benefits, claims major UK investment body.

Bigger executive pay packets will not fix underperforming organisations. It’s a long game and needs a longer-term solution.